Aclarion Provides Update on Strength of Company Positioning Following Q1 Strategic Initiatives

Over $20M raised in Q1 with nearly$15M cash on hand No debt, no preferred equity, and no warrants with strike prices near the current market "The Company is accelerating across all areas of execution," said Brent Ness, CEO of Aclarion. "In addition to strong momentum enrolling CLARITY sites, we've made meaningful commercial progress. We're also driving adoption in London, where we recently secured payer approvals and have built deep support among referring physicians and radiologists. Beyond London, we're ...